Join the club for FREE to access the whole archive and other member benefits.

Neurona gets $120 million to develop cell therapies for brain disorders

09-Feb-2024

Key points from article :

Neurona Therapeutics raised $120 million to progress cell therapies for brain diseases like epilepsy and Alzheimer's.

Their therapy uses implanted cells that release calming signals to repair faulty brain connections.

Early results in epilepsy are promising, potentially offering seizure control and memory protection.

They're also developing cells to repair a different brain structure damaged in Alzheimer's.

Genetically engineered cells are planned to deliver other helpful molecules directly to the brain.

This funding will advance clinical trials for both epilepsy and Alzheimer's, plus explore other brain diseases.

Their treatment uses implanted cells to calm brain activity and repair damaged networks

Mentioned in this article:

Click on resource name for more details.

Neurona Therapeutics

Innovators in neural cell therapies

Neurona gets $120 million to develop cell therapies for brain disorders